Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,882 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cost-effectiveness of transcranial magnetic stimulation vs. electroconvulsive therapy for severe depression: a multi-centre randomised controlled trial.
Knapp M, Romeo R, Mogg A, Eranti S, Pluck G, Purvis R, Brown RG, Howard R, Philpot M, Rothwell J, Edwards D, McLoughlin DM. Knapp M, et al. Among authors: edwards d. J Affect Disord. 2008 Aug;109(3):273-85. doi: 10.1016/j.jad.2008.01.001. Epub 2008 Feb 11. J Affect Disord. 2008. PMID: 18262655 Clinical Trial.
The clinical effectiveness and cost of repetitive transcranial magnetic stimulation versus electroconvulsive therapy in severe depression: a multicentre pragmatic randomised controlled trial and economic analysis.
McLoughlin DM, Mogg A, Eranti S, Pluck G, Purvis R, Edwards D, Landau S, Brown R, Rabe-Heskith S, Howard R, Philpot M, Rothwell J, Romeo R, Knapp M. McLoughlin DM, et al. Among authors: edwards d. Health Technol Assess. 2007 Jul;11(24):1-54. doi: 10.3310/hta11240. Health Technol Assess. 2007. PMID: 17580003 Free article. Clinical Trial.
A randomized, controlled trial with 6-month follow-up of repetitive transcranial magnetic stimulation and electroconvulsive therapy for severe depression.
Eranti S, Mogg A, Pluck G, Landau S, Purvis R, Brown RG, Howard R, Knapp M, Philpot M, Rabe-Hesketh S, Romeo R, Rothwell J, Edwards D, McLoughlin DM. Eranti S, et al. Among authors: edwards d. Am J Psychiatry. 2007 Jan;164(1):73-81. doi: 10.1176/ajp.2007.164.1.73. Am J Psychiatry. 2007. PMID: 17202547 Clinical Trial.
Predictors of response to amine-specific antidepressants.
Burns RA, Lock T, Edwards DR, Katona CL, Harrison DA, Robertson MM, Nairac B, Abou-Saleh MT. Burns RA, et al. Among authors: edwards dr. J Affect Disord. 1995 Dec 13;35(3):97-106. doi: 10.1016/0165-0327(95)00039-9. J Affect Disord. 1995. PMID: 8749837 Clinical Trial.
Placebo-controlled trial of lithium augmentation of fluoxetine and lofepramine.
Katona CL, Robertson MM, Abou-Saleh MT, Nairac BL, Edwards DR, Lock T, Burns R, Harrison DA, Taylor NS. Katona CL, et al. Among authors: edwards dr. Int Clin Psychopharmacol. 1993 Winter;8(4):323. doi: 10.1097/00004850-199300840-00020. Int Clin Psychopharmacol. 1993. PMID: 8277156 Clinical Trial. No abstract available.
Platelet 5-HT uptake sites, labelled with [3H] paroxetine, in controls and depressed patients before and after treatment with fluoxetine or lofepramine.
Lawrence KM, Katona CL, Abou-Saleh MT, Robertson MM, Nairac BL, Edwards DR, Lock T, Burns RA, Harrison DA, Horton RW. Lawrence KM, et al. Among authors: edwards dr. Psychopharmacology (Berl). 1994 Jun;115(1-2):261-4. doi: 10.1007/BF02244781. Psychopharmacology (Berl). 1994. PMID: 7862905 Clinical Trial.
3,882 results